[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345511-105":59,"doc-detail-345511-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-complex-role-of-il-37-in-cancer-pathogenesis-exploring-its-influence-on-hallmarks-of-cancer","The complex role of IL-37 in cancer pathogenesis - exploring its influence on hallmarks of cancer","","Interleukin-37 (IL-37) is widely recognized for anti-inflammatory activity, yet its function in cancer pathogenesis shows a complex, context-dependent influence. This review examines IL-37’s effects on core hallmarks of cancer, including tumor cell proliferation, invasion, metastasis, and immune interactions. It highlights how IL-37 may either suppress or support tumor growth depending on tumor type, stage, and tumor microenvironment factors. The dual nature supports IL-37 as a potential therapeutic target and biomarker, pending validation through prospective clinical studies. By synthesizing recent findings, the review clarifies IL-37’s contributions and informs personalized treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-complex-role-of-il-37-in-cancer-pathogenesis-exploring-its-influence-on-hallmarks-of-cancer/345511/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-complex-role-of-il-37-in-cancer-pathogenesis-exploring-its-influence-on-hallmarks-of-cancer/345511.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this review on IL-37 in cancer?","Question",{"text":112,"@type":113},"The review focuses on how IL-37 influences cancer pathogenesis by affecting multiple hallmarks of cancer, including tumor growth, invasion, metastasis, and immune system interactions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why can IL-37 have both anti-tumor and pro-tumor effects?",{"text":117,"@type":113},"IL-37’s impact is context-dependent, varying with factors such as tumor type, disease stage, and the surrounding tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the hallmarks of cancer relate to IL-37 research?",{"text":121,"@type":113},"The hallmarks of cancer provide a biologically meaningful framework to evaluate IL-37’s diverse functions and understand its possible roles in cancer development and progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345511,1790147041,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Review  \nPUBLISHED 19 May 2026  \nDOI 10.3389/fimmu.2026.1738156  \nOPEN ACCESS  \nEDITED BY  \nQinglei Hang,  \nYangzhou University, China  \nREVIEWED BY  \nKosuke Kawaguchi, Kyoto University, Japan Emir Begagic,  \nCantonal Hospital Zenica, Bosnia and Herzegovina  \n*CORRESPONDENCE  \nMaria-Ioanna Christodoulou  \n [mar.christodoulou@euc.ac.cy](mar.christodoulou@euc.ac.cy)[ ](mar.christodoulou@euc.ac.cy)Stamatios Theocharis  \n[stamtheo@med.uoa.gr](stamtheo@med.uoa.gr)[ ](stamtheo@med.uoa.gr)†These authors have contributed equally to this work  \nRECEIVED 03 November 2025  \nREVISED 23 March 2026  \nACCEPTED 04 May 2026  \nPUBLISHED 19 May 2026  \nCITATION  \nPapadakos SP, Stergiou IE, Andreou MS, Stouras I, Chatzikalil E, Tzimou M, Karantanou C, Christodoulou M-I and Theocharis S (2026) The complex role of IL-37 in cancer pathogenesis: exploring its inﬂuence on hallmarks of cancer. Front. Immunol. 17:1738156 .  \ndoi: 10.3389/fimmu.2026.1738156  \nCOPYRIGHT  \n© 2026 Papadakos, Stergiou, Andreou, Stouras, Chatzikalil, Tzimou, Karantanou, Christodoulou and Theocharis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe complex role of  \nIL-37 in cancer pathogenesis: exploring its inﬂuenceon hallmarks of cancer  \nStavros P. Papadakos 1†, Ioanna E. Stergiou 1,2†, Maria S. Andreou 3, Ioannis Stouras 1, Elena Chatzikalil 1, Maria Tzimou 1,  \nChristina Karantanou 4, Maria-Ioanna Christodoulou 3* and Stamatios Theocharis 1*  \n1 First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece, 2 Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 3Tumor Immunology and Biomarkers Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, School of Sciences, European University Cyprus., Nicosia, Cyprus, 4 Department of Medicine, School of Medicine, European University Cyprus, Frankfurt am Main, Germany  \nInterleukin-37 (IL-37) is a cytokine primarily known for its anti-inﬂammatory properties, but its role in cancer pathogenesis reveals a complex and multifaceted inﬂuence. This review explores IL-37 ’s diverse effects on fundamental hallmarks of cancer, such as tumor cell proliferation, invasion, metastasis, and interactions with the immune system. We discuss how IL-37 can modulate these processes indifferent contexts—sometimes impeding tumor growth and other times facilitating it—depending on factors including the tumor type, stage, and surrounding microenvironment. The dual nature of IL-37 ’s inﬂuence underscores its potential as both a therapeutic target and a biomarker for cancer progression, which remain to be validated in prospective clinical studies. By integrating recent ﬁndings, this review aims to provide a comprehensive understanding of IL-37 ’s contributions to cancer biology, offering insights into its possible future applications in personalized cancer treatment strategies and enhancing our ability to tailor interventions based on the speciﬁc roles of IL-37 in individual cancers.  \nKEYWORDS  \ncancer pathogenesis, hallmarks of cancer, IL-37, immunotherapy, inﬂammation  \n1 Introduction  \nHuman cancer is considered the leading cause of death and treatment-related morbidity worldwide (1). Drastic improvements in survivorship have been achieved, with encouraging results in patients’ clinical outcomes for some diagnoses (e.g., ALL, Hodgkin lymphoma) . However, other types remain intractable (e.g., metastatic HCC), characterized by a plateau in patients’ survival after years of using the available therapies in c","cbCaih2PDjDs0y6V","https://ap.wps.com/l/cbCaih2PDjDs0y6V","pdf",1463455,21,"English","# Introduction\n## Interleukin-37 and anti-inflammatory context\n## Hallmarks of cancer and tumor microenvironment\n## Clinical rationale for investigating IL-37","[{\"question\":\"What is the main focus of this review on IL-37 in cancer?\",\"answer\":\"The review focuses on how IL-37 influences cancer pathogenesis by affecting multiple hallmarks of cancer, including tumor growth, invasion, metastasis, and immune system interactions.\"},{\"question\":\"Why can IL-37 have both anti-tumor and pro-tumor effects?\",\"answer\":\"IL-37’s impact is context-dependent, varying with factors such as tumor type, disease stage, and the surrounding tumor microenvironment.\"},{\"question\":\"How do the hallmarks of cancer relate to IL-37 research?\",\"answer\":\"The hallmarks of cancer provide a biologically meaningful framework to evaluate IL-37’s diverse functions and understand its possible roles in cancer development and progression.\"}]","The complex role of IL-37 in cancer pathogenesis - exploring its influence on hallmarks of cancer | PDF",1790057929,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75945eae7f6f2e53e30fd28a7b3ad4f7.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a7760481358336e558657818fad8b57.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32757af304de1c69286847f9e88e3f3c.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/196da53c05b8e28f5e939361927faf4d.webp",980,1385]